Apoha, founded in 2021, is a groundbreaking player in the Biotechnology and Life Sciences sectors, operating out of the United Kingdom. With its pioneering slogan, "Pioneering the deployment of sensory intelligence with Liquid Brain®", the company is trailblazing by integrating advanced sensory intelligence into the drug and material discovery process.
The core innovation, Liquid Brain, represents the first machine endowed with sensory intelligence, capable of analyzing samples as small as 10µg. This disruptive technology has the potential to unlock a new class of data that could transform how pharmaceuticals and new materials are developed.
In its latest funding effort, Apoha received a Support Program investment on 01 October 2023, backed by Intel Ignite. This signifies confidence from industry leaders in Apoha's innovative approach and its potential market impact. As the company prepares to scale, its developments promise to be closely watched by both technological and investment communities.